Medicinal liquor for treating cancer and preparation method thereof

Abstract

The invention relates to medicinal liquor for treating cancer and a preparation method thereof. The medicinal liquor consists of the following raw materials in weight ratio: 26 to 36g of astragalus mongholicus, 16 to 26g of eucommia bark, 26 to 36g of fiveleaf gynostemma herb, 16 to 26g of roasted fleece-flower root, 2 to 10g of winterworm summerherb, 16 to 26g of curcuma zedoary, 16 to 26g of raw rehmannia, 10 to 20g of epimedium herb, 16 to 26g of medlar, 16 to 26g of codonopsis pilosula, 10 to 20g of bighead atractylodes rhizome, 10 to 20g of aloe, 16 to 26g of seed of Chinese dodder and 16 to 26g of acanthopanax root. The preparation method comprises the following steps of: soaking the raw materials with 3kg of 50 to 60 percent ethanol for 180 days; filtering to obtain a soaking solution for later use; adding 3kg of water into the filtered residues, decocting with slow fire for 20 to 40 minutes after the mixture is boiled with strong fire, and filtering to obtain filtrate; mixing the soaking solution with the filtrate to obtain the medicinal liquor. The medicinal liquor has no acute toxic reactions, can remarkably inhibit proliferation of cancer cells, effectively improves the body immunity, prolongs patient lives, and improves the living quality.

Description

technical field [0001] The invention relates to a medicinal wine for treating cancer and a preparation method thereof. Background technique [0002] At present, cancer is a serious threat to people's physical and mental health. There are currently 2 million patients in my country, with an increase of 1.7 million every year, and 1.3 million deaths from cancer every year. Statistics at home and abroad show that the mortality rate of cancer has occupied the third place. Patients with early detection can be treated surgically. Most patients are in the middle and late stages when they are discovered, and they can only rely on chemotherapy and radiotherapy. However, while chemotherapy and radiotherapy kill cancer cells, they also kill a large number of normal cells, especially active cells, causing toxic and side effects. , the threat to patients is greater, especially bone marrow suppression and gastrointestinal toxicity. At present, there is no good drug treatment at home and ab...

AI Technical Summary

Problems solved by technology

Patients with early detection can be treated surgically. Most patients are in the middle and late stages when they are discovered, and they can only rely on chemotherapy and radiotherapy. However, while chemotherapy and radiotherapy kill cancer cells, they also kill a large number of normal cells, especially active cells, causing toxic and side effects. , the threat to the patient is greater, especially the inhibition of bone marrow and gastrointestinal toxicity. At present, there is no good drug treatment at home and abroad. The decrease in blood cells (decrease in WBC, decrease in RBC, and decrease in PC) caused by bone marrow suppression directly affects the treatment of patients.

[0003] At present, the better drug for increasing blood cells in China is cell colony stimulating factor. It increases WBC faster, but the quality is poor and declines quickly. The blood cells still cannot rise, and the price is expensive. Generally, patients can’t afford it and give up treatment. Long-term application of cell colony stimulating factor may leave toxic side effects of cell mutation